|Bid||392.00 x 1100|
|Ask||400.98 x 1100|
|Day's Range||396.52 - 401.91|
|52 Week Range||305.63 - 456.23|
|Beta (5Y Monthly)||0.75|
|PE Ratio (TTM)||76.89|
|Earnings Date||Jul. 26, 2021 - Jul. 30, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||476.30|
BURNABY, British Columbia, Jun 11, 2021--Dexcom announces that people with diabetes may now be eligible for provincial coverage of the Dexcom G6 CGM System through BC PharmaCare.
Investing in the stock market can be as simple or complicated as you make it out to be. While you can certainly make a case for meme stocks being good long-term investments, the temptation for many investors these days is to try and make a significant amount of money in a very short time. Without much of an established business, investors have been speculating on the success of a COVID-19 vaccine candidate, Covaxin, that Ocugen is co-developing with Indian company Bharat Biotech.
Dexcom Looks to the Future of Continuous Glucose Monitoring